MASS - 908 Devices Inc. Stock Price, Fair Value and News

5.70USD-0.06 (-1.04%)Market Closed

Market Summary

USD5.70-0.06

Market Closed

-1.04%

MASS Alerts

1 major insider buys recently.

MASS Stock Price

View Fullscreen

MASS RSI Chart

MASS Valuation

Market Cap

198.6M

Price/Earnings (Trailing)

-5.71

Price/Sales (Trailing)

3.92

EV/EBITDA

-2.96

Price/Free Cashflow

-7.78

MASS Price/Sales (Trailing)

MASS Profitability

Operating Margin

51.13%

EBT Margin

-69.07%

Return on Equity

-22.16%

Return on Assets

-18.32%

Free Cashflow Yield

-12.85%

MASS Fundamentals

MASS Revenue

Revenue (TTM)

50.7M

Rev. Growth (Yr)

5.31%

Rev. Growth (Qtr)

-30.38%

MASS Earnings

Earnings (TTM)

-34.8M

Earnings Growth (Yr)

13.02%

Earnings Growth (Qtr)

-46.73%

Breaking Down MASS Revenue

52 Week Range

5.6810.37

(Low)(High)

Last 7 days

1.6%

Last 30 days

-17.5%

Last 90 days

-19.4%

Trailing 12 Months

-25.6%

How does MASS drawdown profile look like?

MASS Financial Health

Current Ratio

8.37

Debt/Equity

0.1

Debt/Cashflow

-1.58

MASS Investor Care

Shares Dilution (1Y)

7.23%

Diluted EPS (TTM)

-1.07

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	50.7M	0	0	0
2023	48.0M	49.0M	47.5M	50.2M
2022	45.0M	47.8M	51.0M	46.9M
2021	28.4M	25.6M	32.1M	42.2M
2020	0	0	0	26.9M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of 908 Devices Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 09, 2024	knopp kevin j.	bought	58,300	5.83	10,000	president and ceo
May 08, 2024	knopp kevin j.	bought	57,200	5.72	10,000	president and ceo
May 07, 2024	knopp kevin j.	bought	56,000	5.6	10,000	president and ceo
Apr 16, 2024	knopp kevin j.	acquired	82,250	1.75	47,000	president and ceo
Apr 01, 2024	brown christopher d.	acquired	6,300	1.75	3,600	chief product officer
Mar 26, 2024	griffith joseph h. iv	acquired	13,330	1.58	8,437	chief financial officer
Mar 04, 2024	hunt anthony	acquired	-	-	2,057	-
Feb 22, 2024	eloi fenel m	acquired	-	-	508	-
Feb 22, 2024	george jeffrey p.	acquired	-	-	508	-
Feb 02, 2024	griffith joseph h. iv	sold	-68,873	7.0923	-9,711	chief financial officer

Which funds bought or sold MASS recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 08, 2024	STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	new	-	90,713	90,713	-%
May 08, 2024	US BANCORP \DE\	added	1.24	-37,920	81,057	-%
May 07, 2024	SUSQUEHANNA INTERNATIONAL GROUP, LLP	sold off	-100	-333,582	-	-%
May 07, 2024	NEW YORK STATE COMMON RETIREMENT FUND	added	3.58	-252,000	579,000	-%
May 07, 2024	49 WEALTH MANAGEMENT, LLC	reduced	-1.87	-116,828	177,820	0.04%
May 06, 2024	SG Americas Securities, LLC	sold off	-100	-133,000	-	-%
May 03, 2024	SIGNATUREFD, LLC	unchanged	-	-9,175	18,875	-%
May 02, 2024	Nikko Asset Management Americas, Inc.	reduced	-3.39	-2,307,790	4,228,450	0.04%
May 02, 2024	NISA INVESTMENT ADVISORS, LLC	added	1.04	-8,664	18,399	-%
May 01, 2024	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	sold off	-	-	-	-%

Are Funds Buying or Selling MASS?

Are funds buying MASS calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own MASS

No. of Funds

MASS Alerts

1 major insider buys recently.

Unveiling 908 Devices Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	ameriprise financial inc	5.84%	1,889,627	SC 13G
Feb 14, 2024	eventide asset management, llc	4.42%	1,430,995	SC 13G/A
Feb 14, 2024	granahan investment management, llc	6.30%	2,038,658	SC 13G
Feb 13, 2024	vanguard group inc	5.39%	1,744,330	SC 13G
Feb 09, 2024	arch venture fund vii, l.p.	17.7%	5,725,045	SC 13G/A
Jan 31, 2024	blackrock inc.	5.5%	1,786,753	SC 13G/A
Jan 29, 2024	ark investment management llc	13.42%	4,346,579	SC 13G/A
Nov 13, 2023	alger associates inc	3.8%	1,227,494	SC 13G/A
Feb 14, 2023	alger associates inc	8.8%	2,805,216	SC 13G/A
Feb 14, 2023	eventide asset management, llc	7.0%	2,230,665	SC 13G

Recent SEC filings of 908 Devices Inc.

View All Filings

Date Filed	Form Type	Document
May 10, 2024	4	Insider Trading
May 09, 2024	4	Insider Trading
May 08, 2024	4	Insider Trading
May 07, 2024	4	Insider Trading
May 03, 2024	10-Q	Quarterly Report
Apr 30, 2024	8-K	Current Report
Apr 30, 2024	8-K	Current Report
Apr 29, 2024	ARS	ARS
Apr 29, 2024	DEFA14A	DEFA14A
Apr 29, 2024	DEF 14A	DEF 14A

Peers (Alternatives to 908 Devices Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	182.1B	40.3B	-6.91%	-5.44%	32.37	4.52	-2.84%	-3.08%
BDX	67.9B	19.7B	-4.40%	-6.39%	50.95	3.44	4.82%	-17.56%
ALGN	21.1B	3.9B	-15.05%	-8.09%	45.66	5.39	5.72%	46.72%
BAX	18.3B	14.9B	-16.06%	-18.00%	6.92	1.23	2.98%	207.68%
MID-CAP
ATR	9.9B	3.5B	6.22%	24.59%	31.58	2.79	6.16%	35.06%
HSIC	9.4B	12.5B	0.31%	-3.70%	24.24	0.76	-0.61%	-18.83%
BIO	7.9B	2.6B	-18.28%	-24.14%	-24.53	3.04	-6.25%	-68.62%
XRAY	5.9B	3.9B	-14.09%	-31.22%	-62.62	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	-0.49%	17.89%	-215.82	8.88	30.82%	65.57%
PDCO	2.4B	6.6B	-0.94%	-	12.18	0.36	2.78%	-0.87%
SMALL-CAP
AHCO	1.2B	3.2B	-11.83%	-17.09%	-1.76	0.38	7.94%	-1661.78%
ANIK	374.6M	169.3M	-2.43%	-	-4.88	2.21	7.49%	-244.90%
ANGO	245.1M	324.0M	-12.34%	-33.15%	-1.27	0.76	-3.19%	-337.41%
APYX	57.5M	50.5M	17.69%	-50.29%	-2.52	1.14	14.25%	-10.06%
AEMD	3.1M	3.7M	-28.92%	247.06%	-0.25	0.82	5.77%	8.23%

908 Devices Inc. News

Latest updates

908 Devices Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1
Revenue	-30.4%	9,991,000	14,351,000	14,297,000	12,094,000	9,487,000	11,643,000	15,797,000	11,106,000	8,306,000	15,841,000	12,545,000	8,277,000	5,543,000	5,717,000	6,048,000	11,128,000	4,001,000
Cost Of Revenue	-29.5%	4,988,000	7,076,000	6,428,000	6,300,000	5,103,000	5,721,000	6,459,000	4,472,000	4,177,000	6,707,000	5,733,000	3,898,000	2,635,000	3,138,000	2,212,000	4,718,000	1,903,000
Gross Profit	-31.2%	5,003,000	7,275,000	7,869,000	5,794,000	4,384,000	5,922,000	9,338,000	6,634,000	4,129,000	9,134,000	6,812,000	4,379,000	2,908,000	2,579,000	3,836,000	6,410,000	2,098,000
Operating Expenses	4.1%	17,691,000	16,988,000	16,958,000	16,733,000	17,401,000	16,260,000	16,492,000	15,003,000	13,650,000	12,662,000	12,088,000	11,834,000	8,718,000	6,465,000	5,129,000	4,282,000	4,862,000
S&GA Expenses	3.1%	11,901,000	11,544,000	11,421,000	11,208,000	12,003,000	11,598,000	11,826,000	10,710,000	9,745,000	8,917,000	8,786,000	8,779,000	5,753,000	4,183,000	3,178,000	2,436,000	2,706,000
R&D Expenses	6.4%	5,790,000	5,444,000	5,537,000	5,525,000	5,398,000	4,662,000	4,666,000	4,293,000	3,905,000	3,745,000	3,302,000	3,055,000	2,965,000	2,282,000	1,951,000	1,846,000	2,156,000
EBITDA Margin	7.5%	-0.63	-0.68	-0.65	-0.63	-0.64	-0.68	-	-	-	-	-	-	-	-	-	-	-
Interest Expenses	-	-	-	-350,000	-	551,000	61,000	33,000	15,000	20,000	40,000	31,000	39,000	376,000	244,000	245,000	246,000	241,000
Income Taxes	-877.8%	-70,000	9,000	-87,000	-71,000	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings Before Taxes	-47.4%	-10,987,000	-7,456,000	-7,180,000	-9,417,000	-12,532,000	-	-6,259,000	-8,099,000	-	-	-	-	-	-	-	-	-
EBT Margin	5.2%	-0.69	-0.73	-0.71	-0.68	-0.70	-0.72	-	-	-	-	-	-	-	-	-	-	-
Net Income	-46.7%	-10,900,000	-7,428,500	-7,093,000	-9,346,000	-12,532,000	-9,790,500	-6,259,000	-8,099,000	-9,415,000	-3,465,000	-5,185,000	-7,424,000	-6,095,000	-10,226,000	-1,722,000	2,095,000	-2,966,000
Net Income Margin	5.4%	-0.69	-0.72	-0.82	-0.77	-0.76	-0.72	-0.53	-0.55	-0.57	-0.53	-0.90	-1.00	-	-	-	-	-
Free Cashflow	-353.4%	-10,260,000	-2,263,000	-4,807,000	-8,202,000	-11,832,000	-5,728,000	-5,682,000	-10,482,000	-1,083,000	-9,274,000	-2,982,000	-7,921,000	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet														(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4
Assets	-6.5%	190	203	208	211	218	243	249	247	251	261	166	166	172	179
Current Assets	-6.9%	162	174	180	181	188	216	224	239	243	253	157	157	163	171
Cash Equivalents	-13.4%	105	121	118	133	161	188	194	213	223	224	139	141	149	159
Inventory	9.5%	16.00	15.00	16.00	14.00	13.00	13.00	12.00	11.00	10.00	8.00	8.00	8.00	7.00	5.00
Net PPE	-3.8%	3.00	3.00	3.00	3.00	3.00	3.00	3.00	2.00	2.00	2.00	2.00	2.00	1.00	1.00
Goodwill	-2.2%	10.00	10.00	10.00	10.00	10.00	10.00	9.00	-	-	-	-	-	-	-
Liabilities	-12.2%	33.00	37.00	39.00	36.00	38.00	52.00	53.00	46.00	44.00	46.00	44.00	40.00	38.00	40.00
Current Liabilities	-14.3%	19.00	23.00	22.00	20.00	19.00	19.00	19.00	15.00	14.00	15.00	13.00	11.00	9.00	11.00
Long Term Debt	-	-	-	-	-	-	15.00	15.00	15.00	15.00	15.00	15.00	15.00	15.00	14.00
LT Debt, Non Current	-	-	-	-	-	-	15.00	15.00	15.00	15.00	15.00	15.00	15.00	15.00	14.00
Shareholder's Equity	-5.2%	157	165	170	174	181	191	197	201	207	215	123	127	133	139
Retained Earnings	-6.4%	-181	-170	-163	-156	-146	-134	-124	-118	-110	-100	-97.17	-92.00	-84.60	-78.47
Additional Paid-In Capital	0.8%	337	335	332	329	326	324	321	319	317	315	220	219	218	217
Shares Outstanding	1.2%	33.00	33.00	32.00	32.00	32.00	32.00	31.00	31.00	31.00	31.00	28.00	27.00	-	-
Float	-	-	-	-	166	-	-	-	474	-	-	-	675	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																	(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1
Cashflow From Operations	-384.8%	-9,357	-1,930	-4,600	-7,882	-10,647	-5,116	-4,938	-10,410	-466	-9,220	-2,924	-7,305	-9,633	2,332	8,197	-3,230	-3,168
Share Based Compensation	13.0%	2,643	2,339	2,704	2,578	2,166	2,004	2,020	1,894	1,289	873	811	481	339	307	83.00	69.00	66.00
Cashflow From Investing	-224.7%	-5,780	4,636	-9,915	-19,936	-1,185	-612	-14,506	-72.00	-617	-54.00	-58.00	-616	-9.00	-	175	-93.00	-91.00
Cashflow From Financing	-1463.2%	-1,295	95.00	-248	-401	-15,381	411	171	467	130	94,532	483	276	-566	137,183	5.00	1.00	3.00

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

MASS Income Statement

2024-03-31

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue	$ 9,991	$ 9,487
Cost of revenue	4,988	5,103
Gross profit	5,003	4,384
Operating expenses:
Research and development	5,790	5,398
Selling, general and administrative	11,901	12,003
Total operating expenses	17,691	17,401
Loss from operations	(12,688)	(13,017)
Other income, net:
Interest income	1,729	1,017
Interest expense		(551)
Other (expense) income, net	(28)	19
Total other income, net	1,701	485
Loss from operations before income taxes	(10,987)	(12,532)
Benefit for income taxes	70
Net loss	$ (10,917)	$ (12,532)
Net loss per share, basic	$ (0.33)	$ (0.39)
Net loss per share, diluted	$ (0.33)	$ (0.39)
Weighted average common shares outstanding, basic	32,710,894	31,965,799
Weighted average common shares outstanding, diluted	32,710,894	31,965,799
Product revenue
Revenue	$ 7,233	$ 7,022
Cost of revenue	3,210	3,786
Service revenue
Revenue	2,758	2,240
Cost of revenue	$ 1,778	1,270
Contract revenue
Revenue		225
Cost of revenue		$ 47

MASS Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 104,599	$ 121,041
Marketable securities	29,596	24,641
Accounts receivable, net of allowance for credit losses of $420 and $395 at March 31, 2024 and December 31, 2023	7,486	8,989
Inventory	16,356	14,938
Prepaid expenses and other current assets	3,831	4,181
Total current assets	161,868	173,790
Operating lease, right-of-use assets	5,754	6,233
Property and equipment, net	3,215	3,342
Goodwill	10,139	10,367
Intangible assets, net	7,468	7,860
Other long-term assets	1,347	1,389
Total assets	189,791	202,981
Current liabilities:
Accounts payable	1,472	1,191
Accrued expenses	5,299	8,713
Deferred revenue	10,483	10,629
Operating lease liabilities	2,076	2,016
Total current liabilities	19,330	22,549
Operating lease liabilities, net of current portion	3,380	3,929
Deferred revenue, net of current portion	7,871	8,571
Deferred income taxes	2,317	2,441
Total liabilities	32,898	37,490
Commitments and contingencies (Note 12)
Stockholders' equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued or outstanding at March 31, 2024 and December 31, 2023, respectively
Common stock, $0.001 par value; 100,000,000 shares authorized; 32,924,097 shares and 32,519,023 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	33	33
Additional paid-in capital	337,396	334,692
Accumulated other comprehensive income	980	1,365
Accumulated deficit	(181,516)	(170,599)
Total stockholders' equity	156,893	165,491
Total liabilities and stockholders' equity	$ 189,791	$ 202,981

About 908 Devices Inc.

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

CEO	Dr. Kevin J. Knopp Ph.D.
WEBSITE	908devices.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	227

908 Devices Inc. Frequently Asked Questions

What is the ticker symbol for 908 Devices Inc.? What does MASS stand for in stocks?

MASS is the stock ticker symbol of 908 Devices Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of 908 Devices Inc. (MASS)?

As of Thu May 09 2024, market cap of 908 Devices Inc. is 198.63 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MASS stock?

You can check MASS's fair value in chart for subscribers.

What is the fair value of MASS stock?

You can check MASS's fair value in chart for subscribers. The fair value of 908 Devices Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of 908 Devices Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MASS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is 908 Devices Inc. a good stock to buy?

The fair value guage provides a quick view whether MASS is over valued or under valued. Whether 908 Devices Inc. is cheap or expensive depends on the assumptions which impact 908 Devices Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MASS.

What is 908 Devices Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu May 09 2024, MASS's PE ratio (Price to Earnings) is -5.71 and Price to Sales (PS) ratio is 3.92. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MASS PE ratio will change depending on the future growth rate expectations of investors.